Literature DB >> 2374675

Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (Cipro)

T R Vrabec1, R C Sergott, E A Jaeger, P J Savino, T M Bosley.   

Abstract

Bilateral acute visual loss characterized by cecocentral scotomas and acquired dyschromatopsia developed in a patient receiving large oral doses of ciprofloxacin hydrochloride (Cipro). The visual defects improved after cessation of this antibiotic. To our knowledge, this association has not been described previously. The use of this medication in high doses must be accompanied by careful monitoring of optic nerve function.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2374675     DOI： 10.1016/s0161-6420(90)32518-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


  3 in total

1.  Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics.

Authors:  Baozhong Zhao; Colin F Chignell; Mustapha Rammal; Frank Smith; Mary G Hamilton; Usha P Andley; Joan E Roberts
Journal:  Photochem Photobiol       Date:  2010-06-01       Impact factor: 3.421

2.  Oral fluoroquinolones and the incidence of rhegmatogenous retinal detachment and symptomatic retinal breaks: a population-based study.

Authors:  Kapil G Kapoor; David O Hodge; Jennifer L St Sauver; Andrew J Barkmeier
Journal:  Ophthalmology       Date:  2014-01-28       Impact factor: 12.079

3.  Toxic Optic Neuropathy: A Rare but Serious Side Effect of Chloramphenicol and Ciprofloxacin.

Authors:  Divya M Radhakrishnan; Ramanuj Samanta; Rajat Manchanda; Sweety Kumari; Ritu Shree; Niraj Kumar
Journal:  Ann Indian Acad Neurol       Date:  2020-06-10       Impact factor: 1.383
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.